<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04645394</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-57-20</org_study_id>
    <nct_id>NCT04645394</nct_id>
  </id_info>
  <brief_title>Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study</brief_title>
  <official_title>Bioavailability of Anthocyanins From Aronia Extract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a quadruple cross-over design, 8 healthy men will receive 3 different formulations of&#xD;
      Aronia extract as well as placebo (placebo, aronia, and fermented aronia in 1/6 and 1/1&#xD;
      concentration). The intervention will be given on four separate days at least three days&#xD;
      apart. Before consumption, 2 fasting blood samples will be taken. Blood will also be sampled&#xD;
      at 60, 120, 240, and 360 minutes post consumption. The blood samples will be analyzed for&#xD;
      polyphenolic content with a special focus on anthocyanins.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods for possible intervention The trial will be executed in accordance with the&#xD;
      guidelines of the declaration of Helsinki and will be approved by The Danish Ethical&#xD;
      Committee (1-10-72-57-20). The study is designed as a randomized acute-crossover study&#xD;
      repeated on 4 separate days. All participants will be screened, and written consent must be&#xD;
      obtained before the initiation of the study. Prior to the first intervention day,&#xD;
      participants will be randomized to the order of the intervention; placebo, 1/6 mg or 1/1&#xD;
      fermented aronia extract or non-fermented aronia extract. In order to prevent any cross&#xD;
      contamination between intervention days, no less than 3 washout days must pass between&#xD;
      intervention days. Participants must be fasting for at least 8 hours with only water allowed.&#xD;
&#xD;
      Participants Participants will be recruited by advertisements as well as social media.&#xD;
      Potential candidates will afterwards be referred to the head of the study who will orally&#xD;
      explain the study. Provided interest from candidate, a written consent must be obtained.&#xD;
      Participants will have the right to end their participation at any given point.&#xD;
&#xD;
      Intervention day and blood collections On intervention days, participants arrive fasting&#xD;
      (water allowed since midnight). The intervention will be randomized as to which of the four&#xD;
      interventions the participants are going to consume on the day. All participants will consume&#xD;
      each intervention of either placebo, 1/6 or 1/1 dose fermented aronia extract or 1/1 dose&#xD;
      from non-fermented aronia extract. 15 mins prior to consuming the intervention, a blood&#xD;
      sample will be collected. Another sample will be collected at time 0 h, after which time the&#xD;
      aronia extract along with 200 mL water must be consumed. Then, at time 60, 120, 240 and 360&#xD;
      min, blood must be collected also. At least 3 washout days must pass between intervention to&#xD;
      ensure no cross contamination.&#xD;
&#xD;
      Biochemical analysis Following a successful collection of 6 blood samples over the course of&#xD;
      360 mins on intervention day, the blood from each participant will be stored at -80°C until&#xD;
      analysis. The blood samples will be coded in an anonymous way to ensure that blood sample&#xD;
      cannot be connected to participant to ensure anonymity. The analysis can be carried out by&#xD;
      means of high-pressure liquid chromatography (HPLC) or an equivalent method. The blood&#xD;
      samples must be evaluated for their possible anthocyanin content as well as their phenolic&#xD;
      compound content.&#xD;
&#xD;
      Statistical analysis Primary outcome is area under the curve (total and incremental) for the&#xD;
      response curves of anthocyanins.&#xD;
&#xD;
      To determine differences between groups, ANOVA test will be carried out. Data are considered&#xD;
      significant if p &lt; 0.05.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 23, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Acute 4-arm crossover intervention.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>area under the curve for anthocyanin blood concentration</measure>
    <time_frame>-15, 0, 60, 120, 240, 360 minutes</time_frame>
    <description>Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>incremental area under the curve for anthocyanin blood concentration</measure>
    <time_frame>-15, 0, 60, 120, 240, 360 minutes</time_frame>
    <description>Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of polyphenols in the blood</measure>
    <time_frame>-15, 0, 60, 120, 240, 360 minutes</time_frame>
    <description>Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antioxidant activity in the blood</measure>
    <time_frame>-15, 0, 60, 120, 240, 360 minutes</time_frame>
    <description>Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Bioavailability</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The participants are receiving 1 dose of each in the stated order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fermented aronia high dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants are receiving 1 dose of each in the stated order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fermented aronia low dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants are receiving 1 dose of each in the stated order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aronia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants are receiving 1 dose of each in the stated order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Aronia melanocarpa</intervention_name>
    <description>Administered once (acute study)</description>
    <arm_group_label>Aronia</arm_group_label>
    <arm_group_label>Fermented aronia high dose</arm_group_label>
    <arm_group_label>Fermented aronia low dose</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Chokeberry</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fermented Aronia Melanocarpa high dose</intervention_name>
    <description>Administered once (acute study)</description>
    <arm_group_label>Aronia</arm_group_label>
    <arm_group_label>Fermented aronia high dose</arm_group_label>
    <arm_group_label>Fermented aronia low dose</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Chokeberry</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fermented Aronia Melanocarpa low dose</intervention_name>
    <description>Administered once (acute study)</description>
    <arm_group_label>Aronia</arm_group_label>
    <arm_group_label>Fermented aronia high dose</arm_group_label>
    <arm_group_label>Fermented aronia low dose</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Chokeberry</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered once (acute study)</description>
    <arm_group_label>Aronia</arm_group_label>
    <arm_group_label>Fermented aronia high dose</arm_group_label>
    <arm_group_label>Fermented aronia low dose</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  man between ≥20 ≤75 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Daily usage of medicine, alcohol- or substance abuse&#xD;
&#xD;
          -  BMI ≥30&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine B Christiansen, cand.scient.med.</last_name>
    <phone>+45 28518032</phone>
    <email>c.christiansen@clin.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Søren Gregersen, chief physician, PhD</last_name>
    <phone>30134245</phone>
    <email>soeren.gregersen@aarhus.rm.dk</email>
  </overall_contact_backup>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 20, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2020</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bioavailability</keyword>
  <keyword>Aronia melanocarpa</keyword>
  <keyword>polyphenols</keyword>
  <keyword>anthocyanins</keyword>
  <keyword>healthy</keyword>
  <keyword>men</keyword>
  <keyword>uptake</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

